Byung-Chun Yoo

This inventor holds 7 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: E.i. Dupont De Nemours and Company, Napigen, Inc., Agrigenesis Biosciences Limited. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Byung-Chun Yoo. Retrieved from https://idiyas.com/inventor/byung-chun-yoo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 7)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

3 out of 16,339

E.i. Dupont De Nemours and Company

Agrigenesis Biosciences Limited

patents

4. 1 out of 4

Christiana Care Gene Editing Institute, Inc.

patents

5. 1 out of 16,025

University of California

patents

where one patent can have more than one assignee

Years Active: 2007-2024

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12173295 - Organelle genome modification using polynucleotide guided endonuclease (2024-12-24),

2. 12171813 - Methods of and compositions for reducing gene expression and/or activity (2024-12-24),

3. 11920140 - Organelle genome modification using polynucleotide guided endonuclease (2024-03-05),

4. 10538778 - Sucrose transporter genes for increasing plant seed lipids (2020-01-21),

5. 9976154 - Sucrose transporter genes for increasing plant seed lipids (2018-05-22),

6. 8993840 - Sucrose transporter genes for increasing plant seed lipids (2015-03-31),

7. 7189892 - Nucleic acids encoding phloem small RNA-binding proteins and transgenic plants comprising them (2007-03-13),

Title: Byung-Chun Yoo: Innovator in Genome Modification

Introduction

Byung-Chun Yoo is a prominent inventor based in Newark, DE, known for his significant contributions to the field of genome modification. With a total of seven patents to his name, Yoo has made remarkable advancements in the methods and systems for altering organelle genomes.

Latest Patents

His latest patents include innovative techniques such as "Organelle genome modification using polynucleotide guided endonuclease." This patent outlines methods for altering the genome of an organelle by introducing a recombinant DNA construct that encodes guide RNA and a polynucleotide guided polypeptide. Another notable patent is "Methods of and compositions for reducing gene expression and/or activity," which focuses on reducing the expression or activity of variant genes through the introduction of DNA sequences encoding guide RNAs and CRISPR-associated endonucleases.

Career Highlights

Throughout his career, Byung-Chun Yoo has worked with esteemed companies such as E.I. DuPont De Nemours and Company and Napigen, Inc. His work in these organizations has contributed to the advancement of genetic engineering and biotechnology.

Collaborations

Yoo has collaborated with notable colleagues, including Stephen M. Allen and Howard Glenn Damude, further enhancing his research and innovation in the field.

Conclusion

Byung-Chun Yoo's work in genome modification showcases his dedication to advancing scientific knowledge and technology. His patents reflect a commitment to improving genetic engineering methods, making significant contributions to the field.

Profile summary based on public USPTO records.